• +
  • -
At the beginning of 2014, INC Pharma already started regulatory affairs in MOH in Turkey to get production licence.

Due to the aim, agreements were signed with CRO and CMO for more than 15 products.

Our focused area is especially injectable products which are in a wide therapeutic spectrum

At the beginning of 2016  we got our first production licence and very soon we will launch our own products domestically and internationally

Day by day we expand our product pipe-line. Right now 23 projects are under process, 2 of them licenced, 7 of them were submitted to MOH Turkey and for 7 projects we are filling registration files and 7 other projects are still under development